Literature DB >> 9882312

Envelope formation is blocked by mutation of a sequence related to the HKD phospholipid metabolism motif in the vaccinia virus F13L protein.

R L Roper1, B Moss.   

Abstract

The outer envelope of the extracellular form of vaccinia virus is derived from Golgi membranes that have been modified by the insertion of specific viral proteins, of which the major component is the 37-kDa, palmitylated, nonglycosylated product of the F13L gene. The F13L protein contains a variant of the HKD (His-Lys-Asp) motif, which is conserved in numerous enzymes of phospholipid metabolism. Vaccinia virus mutants with a conservative substitution of either the K (K314R) or the D (D319E) residue of the F13L protein formed only tiny plaques similar to those produced by an F13L deletion mutant, were unable to produce extracellular enveloped virions, and failed to mediate low-pH-induced fusion of infected cells. Membrane-wrapped forms of intracellular virus were rarely detected in electron microscopic images of cells infected with either of the mutants. Western blotting and pulse-chase experiments demonstrated that the D319E protein was less stable than either the K314R or wild-type F13L protein. Most striking, however, was the failure of either of the two mutated proteins to concentrate in the Golgi compartment. Palmitylation, oleation, and partitioning of the F13L protein in Triton X-114 detergent were unaffected by the K314R substitution. These results indicated that the F13L protein must retain the K314 and D319 for it to localize in the Golgi compartment and function in membrane envelopment of vaccinia virus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9882312      PMCID: PMC103931     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Characterization of the membrane association of the influenza virus matrix protein in living cells.

Authors:  J Zhang; R A Lamb
Journal:  Virology       Date:  1996-11-15       Impact factor: 3.616

2.  Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity.

Authors:  T C Sung; R L Roper; Y Zhang; S A Rudge; R Temel; S M Hammond; A J Morris; B Moss; J Engebrecht; M A Frohman
Journal:  EMBO J       Date:  1997-08-01       Impact factor: 11.598

3.  A human homolog of the vaccinia virus HindIII K4L gene is a member of the phospholipase D superfamily.

Authors:  J X Cao; B F Koop; C Upton
Journal:  Virus Res       Date:  1997-04       Impact factor: 3.303

4.  Nucleotide sequence of the vaccinia virus hemagglutinin gene.

Authors:  H Shida
Journal:  Virology       Date:  1986-04-30       Impact factor: 3.616

5.  The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions.

Authors:  E Katz; E J Wolffe; B Moss
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus.

Authors:  E J Wolffe; E Katz; A Weisberg; B Moss
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

7.  Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia.

Authors:  L G Payne
Journal:  J Gen Virol       Date:  1980-09       Impact factor: 3.891

8.  Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release.

Authors:  G Hiller; H Eibl; K Weber
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

9.  Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment.

Authors:  G Hiller; K Weber
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine.

Authors:  L G Payne; K Kristenson
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

View more
  19 in total

1.  Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome.

Authors:  Chris Upton; Stephanie Slack; Arwen L Hunter; Angelika Ehlers; Rachel L Roper
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  Intracellular trafficking of a palmitoylated membrane-associated protein component of enveloped vaccinia virus.

Authors:  Matloob Husain; Bernard Moss
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  Sequence requirements for localization of human cytomegalovirus tegument protein pp28 to the virus assembly compartment and for assembly of infectious virus.

Authors:  Jun-Young Seo; William J Britt
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 4.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

5.  Retrograde Transport from Early Endosomes to the trans-Golgi Network Enables Membrane Wrapping and Egress of Vaccinia Virus Virions.

Authors:  Gilad Sivan; Andrea S Weisberg; Jeffrey L Americo; Bernard Moss
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

6.  Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesicles.

Authors:  M Husain; B Moss
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  Development and comparison of a quantitative TaqMan-MGB real-time PCR assay to three other methods of quantifying vaccinia virions.

Authors:  Jonathon L Baker; Brian M Ward
Journal:  J Virol Methods       Date:  2013-11-08       Impact factor: 2.014

8.  Vaccinia Virus Phospholipase Protein F13 Promotes Rapid Entry of Extracellular Virions into Cells.

Authors:  Peter Bryk; Matthew G Brewer; Brian M Ward
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

9.  Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesis.

Authors:  Shannon McNulty; William Bornmann; Jill Schriewer; Chas Werner; Scott K Smith; Victoria A Olson; Inger K Damon; R Mark Buller; John Heuser; Daniel Kalman
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

10.  Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.

Authors:  Lucas Sánchez-Sampedro; Carmen Elena Gómez; Ernesto Mejías-Pérez; Eva Pérez-Jiménez; Juan Carlos Oliveros; Mariano Esteban
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.